33 research outputs found

    Нерешени аграрно-правни односи у Османском царству као узроци народних покрета код Јужних Словена 1832-1860. године

    Get PDF
    После пораза у рату са Русима и Једренског уговора 1829 г. Порта је покушавала да на основу Танзиматског законодавства уреди и аграрно-правне односе на селу. Посебна уредба великог везира Мехмед Решил паше 1831/32. г. са важношћу за Приштински и друге Косовске пашалуке није била од трајније вредности. Међутим 1830-их година јавља се неколико већих буна јужнословенског становништва у Босни, Румелији и Бугарској

    Optimization of ATM filling-in with cash

    Get PDF
    This report presents an approach for modeling daily cash demand for all ATMs in the Credit Agricole Bank network in Serbia. The approach is based on time series and regression methods for forecasting an optimal amount of money that should be placed daily in the ATMs in order to meet customers’ demands and mimimize costs of the bank. Three different types of costs were considered: cash freezing costs, transportation costs and insurance costs. The performance of the resulting forecasts were compared with results of the application that bank uses for prediciton of the time and the amount of filling-in for each ATM based on historical data

    Optimizing Bus Routes in Nicosia

    Get PDF
    In this report the conclusions by the team of experts that took the ”Trans- portation Organization of the Nicosia District (OSEL)” challenge are provided. The challenge was to identify ways to improve efficiency of the bus network and increase the utilization of the network by the public. A thorough analysis of the various factors that affect bus route planning is provided. Moreover, a demonstration of a simplified route planning problem is described in order to motivate further work on this topic. Recommendations are provided to the company on the way to move forward towards solving the problem of creating a bus network with increased efficiency and grater appeal to the public. Specific recommendations include the collection of a larger amounts of data that can be used to generate models used in simulation analysis. Data include demographic data on bus usage and bus usage preferences by the public. In addition, data is required on bus travel times, walking distance to the nearest bus stop by the commuter, and traffic data

    Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome

    Get PDF
    Apart from well-known functions of bile acids in digestion and solubilization of lipophilic nutrients and drugs in the small intestine, the emerging evidence from the past two decades identified the role of bile acids as signaling, endocrine molecules that regulate the glucose, lipid, and energy metabolism through complex and intertwined pathways that are largely mediated by activation of nuclear receptor farnesoid X receptor (FXR) and cell surface G protein-coupled receptor 1, TGR5 (also known as GPBAR1). Interactions of bile acids with the gut microbiota that result in the altered composition of circulating and intestinal bile acids pool, gut microbiota composition and modified signaling pathways, are further extending the complexity of biological functions of these steroid derivatives. Thus, bile acids signaling pathways have become attractive targets for the treatment of various metabolic diseases and metabolic syndrome opening the new potential avenue in their treatment. In addition, there is a significant effort to unveil some specific properties of bile acids relevant to their intrinsic potency and selectivity for particular receptors and to design novel modulators of these receptors with improved pharmacokinetic and pharmacodynamic profiles. This resulted in synthesis of few semi-synthetic bile acids derivatives such as 6a-ethyl-chenodeoxycholic acid (obeticholic acid, OCA), norursodeoxycholic acid (norUDCA), and 12-monoketocholic acid (12-MKC) that are proven to have positive effect in metabolic and hepato-biliary disorders. This review presents an overview of the current knowledge related to bile acids implications in glucose, lipid and energy metabolism, as well as a potential application of bile acids in metabolic syndrome treatment with future perspectives

    Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics

    Get PDF
    Introduction: In previous studies carried out in our laboratory, a bile acid (BA) formulation exerted a hypoglycaemic effect in a rat model of type-1 diabetes (T1D). When the antidiabetic drug gliclazide (G) was added to the bile acid, it augmented the hypoglycaemic effect. In a recent study, we designed a new formulation of gliclazide-cholic acid (G-CA), with good structural properties, excipient compatibility and exhibits pseudoplastic-thixotropic characteristics. The aim of this study is to test the slow release and pH-controlled properties of this new formulation. The aim is also to examine the effect of CA on G release kinetics at various pH values and different temperatures. Method: Microencapsulation was carried out using our Buchi-based microencapsulating system developed in our laboratory. Using sodium alginate (SA) polymer, both formulations were prepared: G-SA (control) and G-CA-SA (test) at a constant ratio (1:3:30), respectively. Microcapsules were examined for efficiency, size, release kinetics, stability and swelling studies at pH 1.5, pH 3, pH 7.4 and pH 7.8 and temperatures of 20 and 30 °C. Results: The new formulation is further optimised by the addition of CA. CA reduced microcapsule swelling of the microcapsules at pH 7.8 and pH 3 at 30 °C and pH 3 at 20 °C, and, even though microcapsule size remains similar after CA addition, percent G release was enhanced at high pH values (pH 7.4 and pH 7.8, p < 0.01). Conclusion: The new formulation exhibits colon-targeted delivery and the addition of CA prolonged G release suggesting its suitability for the sustained and targeted delivery of G and CA to the lower intestine

    RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice

    No full text
    corecore